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Abstract 
Background: Heterologous protein production in Escherichia coli often suffers from bottlenecks such as proteolytic 
degradation, complex purification procedures and toxicity towards the expression host. Production of proteins in an 
insoluble form in inclusion bodies (IBs) can alleviate these problems. Unfortunately, the propensity of heterologous 
proteins to form IBs is variable and difficult to predict. Hence, fusing the target protein to an aggregation prone poly‑
peptide or IB‑tag is a useful strategy to produce difficult‑to‑express proteins in an insoluble form.
Results: When screening for signal sequences that mediate optimal targeting of heterologous proteins to the 
periplasmic space of E. coli, we observed that fusion to the 39 amino acid signal sequence of E. coli TorA (ssTorA) did 
not promote targeting but rather directed high‑level expression of the human proteins hEGF, Pla2 and IL‑3 in IBs. 
Further analysis revealed that ssTorA even mediated IB formation of the highly soluble endogenous E. coli proteins 
TrxA and MBP. The ssTorA also induced aggregation when fused to the C‑terminus of target proteins and appeared 
functional as IB‑tag in E. coli K‑12 as well as B strains. An additive effect on IB‑formation was observed upon fusion of 
multiple ssTorA sequences in tandem, provoking almost complete aggregation of TrxA and MBP. The ssTorA‑moiety 
was successfully used to produce the intrinsically unstable hEGF and the toxic fusion partner SymE, demonstrating its 
applicability as an IB‑tag for difficult‑to‑express and toxic proteins.
Conclusions: We present proof‑of‑concept for the use of ssTorA as a small, versatile tag for robust E. coli‑based 
expression of heterologous proteins in IBs.
Keywords: Inclusion bodies, Fusion tag, Insolubility, Aggregation, Heterologous protein production, E. coli, Signal 
peptide, Twin‑arginine translocation pathway
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Background
The Gram-negative bacterium Escherichia coli is by far 
the most popular host for the production of recombinant 
proteins in biotechnology because of the high expres-
sion levels that can be achieved, its rapid growth rate, its 
suitability for continuous and high-cell density culturing 
methods and general cost-effectiveness [1].
However, many recombinant polypeptides are prone to 
misfolding upon expression in bacteria due to the high 
rate of translation and the lack of cognate chaperones. 
Also, formation of disulphide bonds is not supported in 
the reducing environment of the bacterial cytosol, which 
may further compromise protein folding and stability. 
Many proteins are toxic to the host cell when expressed 
at high levels and inhibit cell growth or even induce cell 
death, leading to impaired protein production levels. Fur-
thermore, at all stages during expression and purification, 
bacterial proteases may affect the yield of the desired 
product. Even when expression of properly folded solu-
ble protein is achieved, purification and isolation of the 
recombinant proteins from the complex cytoplasm is dif-
ficult and labor intensive [2].
To address some of these problems, recombinant pro-
teins may be routed to the periplasm, which provides an 
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oxidative environment that is favorable for protein fold-
ing, disulphide bond formation and stability [3, 4]. To 
direct recombinant proteins to this compartment, they 
must be fused to an N-terminal signal sequence that 
mediates their targeting to and translocation across the 
bacterial inner membrane via either the Sec-system or 
the twin-arginine translocation (Tat) translocon, depend-
ing on the signal sequence chosen. Signal sequences are 
generally short (20–30 amino acid residues) and com-
prise three domains: a basic domain at the N-terminus, a 
central hydrophobic core, and a C-terminal domain that 
contains a cleavage site for Signal peptidase [5].
In many cases, overexpression of recombinant pro-
teins in the cytosol and sometimes even in the periplasm 
leads to the formation of aggregates that consist almost 
exclusively of the recombinant protein [6]. Using light-
microscopy, these aggregates or inclusion bodies (IBs) 
can be observed as large refractive bodies that are pre-
dominantly located at one or both cell poles [7, 8]. For 
long, IBs were considered to consist solely of unfolded 
or highly misfolded polypeptides. However, it now seems 
clear that, at least in specific cases, a significant part of 
IBs consists of properly folded and biologically active 
protein [9, 10]. Furthermore, expression in IBs seems an 
effective strategy to avoid some of the problems associ-
ated with expression of recombinant proteins in a soluble 
form. Proteins in IBs are largely resistant against degra-
dation by host cell proteases and less likely to exert toxic 
effects. Moreover, due to their high density, IBs are easy 
to isolate from cell lysates by differential centrifugation, 
providing fast, robust and hence cost-efficient [11] pro-
tocols to obtain large amounts of relatively pure pro-
tein [12–14]. Improved methods for refolding partially 
denatured or incompletely folded recombinant proteins 
from IBs further contribute to the current interest in 
the deposition of recombinant protein in IBs [15, 16]. 
Rather than being seen as unwanted byproducts of pro-
tein production, IBs are nowadays regarded as functional 
nanoparticles with potential applications in for example 
biocatalysis, diagnostics, tissue engineering and drug 
delivery [17].
Some recombinant proteins form IBs already at 
relatively low expression levels while others remain 
completely soluble even at extremely high intracellular 
concentrations. Unfortunately, the propensity to form 
IBs is difficult to predict from the recombinant protein 
sequence. However, it has been shown that even intrinsi-
cally soluble proteins often accumulate in IBs when they 
are expressed as a fusion to an aggregation prone poly-
peptide [18]. These so-called IB-tags are convenient tools 
to produce difficult-to-express proteins.
Upon examination of signal sequences that mediate 
optimal targeting of recombinant proteins to the E. coli 
periplasm, we serendipitously found that the 39-amino 
acid long signal sequence of E. coli TMAO-reductase 
(ssTorA) promoted high-level expression of heterolo-
gous proteins in IBs, instead of facilitating translocation 
of these proteins across the cytoplasmic membrane. We 
present data that demonstrate the potential of ssTorA as 
a small, broadly applicable IB-formation tag for robust 
expression of recombinant proteins in IBs.
Results
Signal sequence‑mediated periplasmic expression 
of heterologous proteins
Periplasmic expression has shown to be an effective 
strategy to produce eukaryotic proteins in E. coli. Ini-
tially, we aimed to identify the most effective strategy to 
mediate the periplasmic localization of the recombinant 
human epidermal growth factor (hEGF). This small, 53 
amino acid mitogen has various (potential) applications 
in wound healing and is difficult to produce at industrial 
scale in E. coli due to the presence of three disulphide 
bonds in the native protein [19]. To direct hEGF to the 
periplasm, fusion to various signal sequences for routing 
via different E. coli inner membrane targeting and trans-
location pathways was explored (Fig. 1). The fusion con-
structs were cloned under tetA promoter control [20] and 
expressed in E. coli K-12 strain MC4100 upon addition of 
the inducing agent anhydrotetracycline. After two hours, 
total cell samples of induced and non-induced cultures 
were analyzed by SDS-PAGE and Coomassie staining.
Fusion of hEGF to the signal sequences of PhoE 
(ssPhoE) and Hbp (ssHbp), both mediating inner mem-
brane translocation via the Sec-translocon [21, 22], 
resulted in the accumulation of a 6  kDa product in the 
Fusion Amino acid sequence         Mode of IM targeting/IM translocon
ssTorA/POI mnnndlfqasrrrflaqlggltvagmlgpslltprrasa-POI         Posttranslational/Tat
ssPhoE/POI mkkstlalvvmgivasasasa-POI         Posttranslational/Sec
ssHbp/POI mnriyslrysavargfiavsefarkcvhksvrrlcfpvlllipvlfsagasa-POI         Co- or posttranslational/Sec
ssDsbA/POI mkkiwlalaglvlafsasa-POI Cotranslational/Sec
^SPaseI
Fig. 1 Schematic representation of E. coli signal sequence fusion constructs. Amino acid sequences of the signal sequences of E. coli TorA (ssTorA), 
PhoE (ssPhoE), Hbp (ssHbp) and DsbA (ssDsbA) as fused to a recombinant protein of interest (POI). A universal Ala‑Ser‑Ala sequence (underlined) for 
recognition by Signal peptidase I (SPaseI) replaces the three most C‑terminal residues of each signal sequence
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cells (>) (Fig.  2a, lanes 4 and 6), which could be identi-
fied as hEGF by Western blotting (data not shown). The 
apparent molecular weight of the product suggested 
successful transport of the hEGF-chimeras to the peri-
plasm and subsequent processing of the respective sig-
nal sequences by Signal peptidase I [23]. No clear hEGF 
product was observed upon fusion to the signal sequence 
of DsbA (ssDsbA), a cotranslationally targeted substrate 
of the Sec-translocon [24] (Fig. 2a, lane 8). This suggests 
that fusion to ssDsbA is ineffective in directing efficient 
periplasmic expression of hEGF and the ssDsbA/hEGF 
fusion protein is degraded. Fusion of hEGF to the sig-
nal sequence of the Tat-substrate TorA (ssTorA) [25, 
26] yielded a  ~10  kDa product corresponding to the 
non-processed form of ssTorA/hEGF. The product was 
expressed at remarkably high levels, being by far the most 
abundant protein in the cell lysate (Fig.  2a, lane 2). The 
lack of processing by Signal peptidase I suggests that 
hEGF failed to translocate to the periplasmic space of E. 
coli upon fusion to ssTorA. Similar results were obtained 
a b
ssTorA/hEGF ssTorA/IL-3EVc
Fig. 2 Expression of hEGF and IL‑3 in IBs upon fusion to ssTorA. Expression of either hEGF (a) or IL‑3 (b) upon fusion to the signal sequences (ss) 
of E. coli TorA, PhoE, Hbp or DsbA as indicated. E. coli MC4100 cells were grown to early log‑phase when fusion protein expression was induced by 
addition of anhydrotetracycline (ahtc). Samples were withdrawn from the cultures at the time point of induction (−ahtc) and 2 h after induction 
(+ahtc). Cells were analyzed by SDS‑PAGE and Coomassie staining. Non‑processed (*) and processed (>) forms of the respective fusion proteins are 
indicated. Molecular mass (kDa) markers are indicated at the left side of the panels. c E. coli MC4100 cells carrying pIBA‑ssTorA/hEGF, pIBA‑ssTorA/
IL‑3 or an empty pASK‑IBA3 vector (EV) grown and induced as described under a and b were analyzed by phase‑contrast microscopy. Examples of 
inclusion bodies are indicated with an arrow. Scale bar 2 μm
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when investigating the signal sequence-mediated peri-
plasmic expression of two other human proteins: inter-
leukin-3 (IL-3) (Fig. 2b) and phospholipase A2 (Type V) 
(Pla2) (data not shown). Whereas chimeras compris-
ing Sec-signal sequences showed (low-level) expression 
of processed IL-3 and Pla2, fusion to ssTorA produced 
high amounts of non-processed material in E. coli cells 
(Fig. 2b, lane 2; data not shown).
In conclusion, under the expression conditions used, 
fusion to ssTorA does not support translocation of 
recombinant proteins into the periplasm but rather 
induces high-level expression of the unprocessed form, 
presumably in the cytoplasm.
The TorA signal sequence directs expression 
of heterologous proteins in inclusion bodies
To analyze the distribution of the accumulating ssTorA 
fusion proteins in more detail, E. coli cells were lysed and 
fractionated upon expression of ssTorA/hEGF (Addi-
tional file  1: Figure S1). A small fraction of the fusion 
protein accumulated in the membrane fraction and the 
soluble cytoplasmic fraction (Additional file  1: Figure 
S1, lanes 2 and 4). However, the vast majority of ssTorA/
hEGF co-sedimented with the cellular debris upon low-
speed centrifugation of the spheroplast lysate (Additional 
file 1: Figure S1, lane 5), suggesting that the protein was 
expressed in an insoluble form. As a control, the endoge-
nous soluble cytoplasmic protein Trigger factor, the peri-
plasmic protein DsbA and the (outer) membrane protein 
OmpA, were predominantly localized in the expected 
subcellular fraction, confirming the reliability of the frac-
tionation procedure.
To examine the nature of TorA/hEGF aggregates, the 
low-speed pellet of a total lysate of E. coli cells express-
ing the protein was extracted with the detergent Triton 
X-100, which solubilizes membrane-associated mate-
rial rather than aggregated proteins (Additional file  2: 
Figure S2). The majority of ssTorA/hEGF was detected 
in the pellet fraction (Additional file  2: Figure S2, lane 
2) in contrast to the endogenous outer membrane pro-
tein OmpA, which was only detected in the supernatant 
fraction (Additional file 2: Figure S2, lane 3). Together, 
the data suggest that ssTorA/hEGF is expressed in dense 
cytoplasmic aggregates, also known as inclusion bod-
ies. Consistently, phase-contrast microscopy of E. coli 
cells expressing ssTorA/hEGF showed clear polar foci 
(Fig. 2c). Similar structures were observed upon expres-
sion of ssTorA/IL-3 (Fig. 2c) and ssTorA/Pla2 (data not 
shown), indicating a more general propensity for het-
erologous proteins to accumulate in IBs upon fusion to 
ssTorA. Hence, ssTorA may be applicable as a fusion tag 
that enables efficient production of heterologous pro-
teins in E. coli by directing their deposition in IBs.
The TorA signal sequence directs expression of well‑soluble 
E. coli proteins in inclusion bodies
hEGF, IL-3 and Pla2 are eukaryotic proteins and there-
fore may have some intrinsic tendency to aggregate 
upon expression in the E. coli cytosol. In other words, 
they may constitute relatively easy targets for ssTorA-
mediated production in IBs. To test the ability of ssTorA 
to promote aggregation of more challenging, intrinsi-
cally soluble proteins, ssTorA was fused to the N-ter-
minus of the endogenous E. coli proteins Thioredoxin-1 
(TrxA) and Maltose binding protein (MBP; lacking its 
signal sequence) using the same strategy as described 
for the fusion partners of eukaryotic origin (Fig. 3). Both 
TrxA and MBP remain soluble even at high intracellular 
concentrations of 35–40% of the total cellular protein 
content. In fact, they have been exploited as solubility-
enhancing fusion partners of proteins that are otherwise 
insoluble upon expression in E. coli [27, 28]. IB forma-
tion of the resulting fusion proteins and corresponding 
ssTorA-less controls was analyzed using an IB sedimen-
tation assay. Briefly, E. coli TOP10F’ cells expressing the 
proteins were broken by lysozyme treatment and sonica-
tion, after which the lysate was subjected to low-speed 
centrifugation to separate the dense cell material includ-
ing IBs from the soluble proteins. The resulting fractions 
and a corresponding whole-cell lysate sample were ana-
lyzed by SDS-PAGE and Coomassie staining (Fig. 4a, b).
ssTorA-tagged versions of TrxA and MBP were 
expressed at levels similar to their non-tagged counter-
parts (Fig. 4a, b, cf. lanes 1 and 4). Judged by the inten-
sity of the Coomassie stained bands, the proteins are by 
far the most abundant proteins in the expressing cells. 
Despite the high level of expression, the non-tagged 
proteins were completely recovered in the supernatant 
fraction (Fig.  4a, b, lane 3), confirming their solubility. 
In contrast, most ssTorA/TrxA (62%) and ssTorA/MBP 
(69%) was detected in the low-speed pellet (Fig.  4a, b, 
lane 5), indicating that the tagged proteins were largely 
insoluble upon overexpression. Notably, part of the pop-
ulation of ssTorA/TrxA recovered in the soluble fraction 
appeared unstable and was processed to a lower molec-
ular weight form (>) (Fig.  4a, lane 6; Additional file  3: 
Figure S3), possibly due to a to non-cytosolic protease 
gaining access to the fusion protein upon disruption of 
the whole cells during the fractionation procedure.
In agreement with the biochemical analysis, phase-
contrast microscopy showed very prominent, mostly 
polar localized IBs in cells expressing ssTorA/TrxA and 
ssTorA/MBP, whereas no such structures were observed 
in cells expressing their non-tagged counterparts or 
carrying an empty vector (Fig.  5a). In agreement with 
observations by others [7], overexpression of IB-forming 
proteins seemed to interfere with cell division, resulting 
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in elongated cells with IBs localized at both cell poles. 
Also, interconnected cells were present with IBs posi-
tioned at the old poles and emerging IBs at the inter-
connected new poles (Fig. 5a; black arrow). To get more 
insight into the nature and stability of the IBs, they were 
isolated from disrupted E. coli cells and subjected to an 
extensive washing regime with Triton X-100 detergent 
to remove excess membrane material, urea to break 
low affinity protein interactions and high-salt to break 
potential electrostatic protein interactions. Subsequent 
analysis by electron microscopy revealed a homogenous 
population of particulate structures for both fusion pro-
teins (Additional file 4: Figure S4). With estimated aver-
age diameters of 750 and 350  nm respectively (Fig.  5b; 
Additional file  4: Figure S4), ssTorA/MBP IBs appeared 
significantly larger than the ssTorA/TrxA IBs. Remarka-
bly, whereas ssTorA/TrxA IBs overall had a characteristic 
spherical appearance, many IBs isolated from by ssTorA/
MBP expressing cells displayed flat sides (Additional 
file 4: Figure S4). Possibly, parts of these IBs broke off due 
to the extensive washing regime applied during isolation, 
which involved several rounds of sonication. In any case, 
this analysis confirmed that genuine, stable IBs were gen-
erated upon fusion to ssTorA, although the nature or size 
of the fused cargo protein can have a considerable influ-
ence on the size and appearance of the IBs formed. The 
finding that fusion of ssTorA to the N-terminus of other-
wise highly soluble endogenous E. coli proteins in E. coli 
induces their deposition in IBs underscores the potential 
of ssTorA as a universal IB fusion tag.
Enhanced efficiency of IB‑formation upon fusion 
to multiple ssTorA sequences
Despite the small size of the tag, remarkably efficient IB-
formation of target proteins was observed upon attach-
ment of a single ssTorA sequence. In an attempt to 
further improve the IB-formation process, the N-termini 
of TrxA and MBP were equipped with triple tandem 
repeats of ssTorA (see Fig.  3). The efficiency of insolu-
ble expression was analyzed using the sedimentation 
assay described above. In contrast to the corresponding 
single-ssTorA versions, the triple-ssTorA carrying chi-
meras ssTorA(3x)/TrxA (Fig. 4a, lane 8), and ssTorA(3x)/
MBP (Fig.  4b, lane 8), were exclusively detected in the 
IB-containing low-speed pellet. Notably, although the 
steady-state expression levels of the triple-ssTorA chime-
ras appeared slightly reduced compared to their cognate 
single-ssTorA variants, the absolute amounts of non-sol-
uble material produced appeared significantly increased 
for these constructs (Fig. 4a, b, cf. lanes 5 and 8). Fusion 
of double ssTorA tandem repeats (see Fig.  3) produced 
very similar results (Additional file  5: Figure S5A, B), 
reducing the length of the tag needed to reach optimal 
IB-formation.
Phase-contrast microscopy was performed to analyze 
the effect of multiple tag attachment on the appear-
ance of IBs (Fig. 5a). Expression of triple-tagged fusion 
proteins seemed to yield more IBs per cell compared 
to proteins carrying one tag. In contrast to cargos car-
rying one tag, many examples were found of cells that 
contained structures that seemed to represent clusters 
N-terminal ssTorA fusion
ssTorA/POI
    mnnndlfqasrrrflaqlggltvagmlgpslltprrasa-POI
ssTorA(2x)/POI
    mnnndlfqasrrrflaqlggltvagmlgpslltprrasmnnndlfqasrrrflaqlggltvagmlgpslltprrasa-POI
ssTorA(3x)/POI


















Fig. 3 Schematic representation of ssTorA fusion constructs. Amino acid sequences of ssTorA when fused to the N‑terminus or C‑terminus of a 
recombinant protein of interest (POI), either in single, double, or triple format. As a result of the cloning procedure a threonine residue at the penul‑
timate position of wild‑type ssTorA is replaced by a serine. Furthermore, upon fusion of multiple ssTorA sequences, upstream ssTorA sequences lack 
the ultimate alanine residue
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of multiple of IBs (black arrow heads) rather than sin-
gular IBs. The origin of this remarkable observation 
is as yet unclear and subject to further analysis. Nev-
ertheless, the collective data show that the amounts of 
insoluble protein produced per cell can be improved by 
fusing multiple ssTorA tags to target proteins, rather 
than one tag.
Successful IB‑formation upon fusion of ssTorA to the 
C‑terminus of TrxA
For some target proteins or applications fusion of the tag 
to the C-terminus might be more appropriate, for exam-
ple when the biological activity of proteins produced in 
IBs or refolded from IBs is dependent on a non-modi-
fied N-terminus. To investigate whether a C-terminal 
Fig. 4 IB formation of TrxA and MBP upon fusion to ssTorA. a E. coli TOP10F’ cells expressing the indicated TrxA constructs were lysed and subjected 
to differential centrifugation to separate the inclusion bodies (IB)‑containing insoluble fraction from the soluble cell fraction (S). Samples of both 
fractions and corresponding whole cell (WC) samples were analyzed by SDS‑PAGE and Coomassie staining. All samples were derived from the same 
amount of cell material. b Cells expressing indicated MBP constructs processed and analyzed as described under a. c Cells expressing indicated 
TrxA constructs carrying ssTorA sequence(s) at the C‑terminus processed and analyzed as described under a. Full‑length expression products (*), a 
processed product of ssTorA/TrxA (>) and lysozyme added during the fractionation procedure (Lys) are indicated. Molecular mass (kDa) markers are 
indicated at the left side of the panels. At the bottom of the panels the relative amount of overexpressed protein in the insoluble fraction compared 
to the whole cell lysates is displayed (% INS) as determined by densitometric quantification of the respective Coomassie stained bands. The follow‑
ing calculation was used: (density of protein band in lane IB/density of protein band in lane WC)*100%
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location of the tag is compatible with IB-formation, a 
single-or triple-ssTorA sequence was fused downstream 
of TrxA (see Fig.  3). The resulting TrxA/ssTorA chime-
ras were expressed at a level comparable to TrxA chime-
ras carrying N-terminal ssTorA (cf. Fig. 4a, lane 4, c, lane 
1). Furthermore, very similar to the N-terminal ssTorA 
(Fig. 4a, lane 5), the C-terminal fusion appeared to render 
TrxA mostly insoluble using an IB sedimentation assay 
(Fig.  4c, lane 2). Upon fusion of two (Additional file  5: 
Figure S5C) or three tags almost all material was detected 
in the pellet (Fig.  4c, lane 5), demonstrating enhanced 
insolubility under these conditions, again similar to the 
corresponding N-terminal ssTorA fusions (Fig.  4a, lane 
8). In conclusion, ssTorA functions as an IB-tag at the 
N-terminus and the C-terminus of a target protein with 
approximately equal efficiency.
ssTorA drives IB formation in E. coli K‑12 and B strains
Escherichia coli K-12 and B strains are both employed in 
industrial protein production processes. To exclude that 
ssTorA-mediated IB-formation of target proteins is specific 
for expression in E. coli K-12 strains, like the strains MC4100 
and TOP10F’ used thus far, we analyzed expression and IB-
formation of MBP and ssTorA/MBP under tetA promoter 
control in E. coli B strain BL21(DE3) (Additional file 6: Fig-
ure S6). In this background, the expression levels of MBP and 
ssTorA/MBP were comparable to TOP10F’. The efficiency of 
insoluble expression of ssTorA/MBP in BL21(DE3) appeared 
even slightly higher than in TOP10F’ indicating that the 
ssTorA IB-tag is functional in various E. coli strains.
ssTorA‑mediated production of unstable and toxic proteins
ssTorA may be exploited for the production of proteins 
that are difficult to produce when expressed in E. coli in a 
soluble form. To investigate whether ssTorA can enhance 
the expression of proteins that are unstable in E. coli, it 
was fused to the N-terminus of hEGF, which is poorly 
expressed in E. coli and hardly detectable in a total cell 
lysate (Fig.  6, lane 4). As observed before (Fig.  2a, lane 
2), ssTorA/hEGF expressed under identical conditions 
appeared the most abundant protein in the E. coli lysate 
(Fig. 6, lane 2). Most likely, insoluble expression of hEGF 
upon fusion of ssTorA renders the protein (largely) inac-
cessible to proteolytic degradation in the E. coli cytoplasm 
resulting in dramatically enhanced expression levels.
An alternative cause of impaired recombinant protein 
expression is toxicity of the native protein through inter-
ference with the physiology of the expression host, leading 
to growth defects or even cell death. To analyze the expres-
sion of toxic proteins through the ssTorA-fusion approach, 
ssTorA was fused to the cytoplasmic E. coli toxin SymE 
that is part of the SymE-SymR toxin-antitoxin system 
[29]. Overexpression of this protein has been described to 
decrease protein synthesis, provoke RNA degradation and 
consequently inhibit growth [30]. Indeed, growth of E. coli 
TOP10F’ cells was strongly inhibited upon expression of 
TrxA ssTorA/TrxAEV ssTorA(3x)/TrxA
MBP ssTorA/MBP ssTorA(3x)/MBP ssTorA/MBP
ssTorA/TrxAa b
Fig. 5 Microscopy analysis of IB formation. a E. coli TOP10F’ cells carrying an empty vector (EV) and cells expressing indicated proteins were 
analyzed by phase‑contrast microscopy. Examples of IBs are indicated with a white arrow; examples of IBs seemingly formed at the new‑pole of 
interconnected cells are indicated with a black arrow; examples of clustered IBs are indicated with a black arrowhead. Scale bar 2 μm. b Electron 
microscopy analysis of IBs isolated from TOP10F’ cells overexpressing indicated proteins. Representative IBs of average size are shown. Scale bar 
500 nm
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SymE under control of a tetA promoter with the culture 
reaching an optical density (OD660) of only 0.9 approxi-
mately 3 h after induction of SymE expression (Fig. 7a). In 
contrast, upon tagging of SymE with the ssTorA, growth 
was restored, with the culture reaching an OD660 of more 
than 2.0. To investigate how the influence on cell growth 
relates to the protein expression and solubility, cell sam-
ples of SymE and ssTorA/SymE were taken 2 h after induc-
tion and subjected to the IB sedimentation assay (Fig. 7b). 
The majority of non-tagged SymE appeared present in 
the supernatant fraction (Fig. 7b, lane 3) whereas ssTorA/
SymE was almost exclusively present in the pellet con-
taining insoluble material (Fig.  7b, lane 4). Apparently, 
aggregation of ssTorA/SymE alleviates the toxic effects 
associated with overexpression of SymE in soluble form. 
Taken together, the data suggest that fusion to ssTorA is an 
effective strategy to produce difficult-to-express proteins, 
such as unstable and toxic proteins, in E. coli.
Discussion
Here, we present a proof-of-concept study that demon-
strates the potential of ssTorA as a tool for high-level 
insoluble protein expression, to allow for straightfor-
ward and cost-efficient recombinant protein production. 
We show that fusion of ssTorA mediates aggregation of 
all tested proteins including those that are soluble even 
when expressed at high intracellular concentrations 
(TrxA and MBP). Conveniently, ssTorA is functional at 
both the N-terminus and C-terminus of target proteins 
and can be employed in E. coli K-12 as well as B strains. 
An even stronger aggregation propensity was observed 
upon fusion of multiple ssTorA sequences in tandem 
allowing almost complete aggregation even of the highly 
soluble TrxA and MBP proteins. To demonstrate its 
applicability, ssTorA was successfully used to overpro-
duce intrinsically unstable hEGF in E. coli and to improve 
growth of host bacteria upon expression of the toxic 
SymE protein.
The use of fusion tags to facilitate the insoluble 
expression of target proteins has been reported previ-
ously. Examples of insolubility tags include trpΔLE [31], 
ketosteroid isomerase [32], β-galactosidase [33], PagP 
[34], EDDIE [35], ELK16 [36], GFIL8 [37], PaP3.30 [38], 
TAF12-HFD [39] and the F4 fragment of PurF [40]. Most 
described tags comprise relatively large sequences [31, 
34, 35, 38, 40] that may adversely affect the yield of the 
target protein or compromise downstream applications. 
Smaller IB-tags have been presented but were used for 
the production of short polypeptides [39] or the effi-
ciencies of IB formation and final yield of protein were 
difficult to evaluate [36, 41]. In addition, some of the tar-
get proteins analyzed in combination with small IB-tags 
seemed to possess an intrinsic tendency to form aggre-
gates in the E. coli cytoplasm, making it difficult to evalu-
ate the added value of the IB-tag [36, 37, 41, 42]. Here, 
we demonstrated that fusion of a single 39 amino acid 
ssTorA tag is sufficient to provoke efficient accumulation 
of the sizeable proteins TrxA and MBP into IBs, whereas 
no significant IB formation was observed for the corre-
sponding non-tagged proteins expressed at similar lev-
els (Fig. 4). Virtually complete deposition in IBs could be 
achieved upon attachment of a second (Additional file 5: 
Figure S5) or third tag (Fig. 4). Given that both TrxA and 
MBP are extensively used as fusion partner to enhance 
the solubility of heterologous proteins in E. coli [43], 
these results are striking and attest to the usefulness of 
ssTorA as an IB-tag.
The interest in IBs has been revived by recent studies 
showing that aggregated proteins can retain native-like 
conformations. Rather than being amorphous aggregates 
Fig. 6 Expression of hEGF in the absence and presence of fused 
ssTorA. E. coli HDB37 cells were grown to early log‑phase when 
expression of either hEGF or ssTorA/hEGF was induced by addition 
of anhydrotetracycline (ahtc). Samples were withdrawn from the cul‑
tures at the time point of induction (−ahtc) and 2 h after induction 
(+ahtc). Cells were analyzed by SDS‑PAGE and Coomassie staining. 
Expression products hEGF and ssTorA/hEGF are indicated (*). Molecu‑
lar mass (kDa) markers are indicated at the left side of the panels
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of disordered proteins, IBs show a structured β-sheet 
organization and bind amyloid specific dyes [44]. Fur-
thermore, in some cases IBs were shown to contain a sig-
nificant portion of properly folded and biologically active 
protein [17], showing potential for novel industrial and 
biomedical applications. Interestingly, fusion of a triple 
ssTorA tag to GFP yielded IBs that emitted a fluorescence 
signal, hence containing properly folded GFP (Additional 
file  7: Figure S7). This observation alludes to a compat-
ibility of the ssTorA tag with the production of bioactive 
IBs. The relative amounts of functional protein present 
in these IBs and the question whether the production of 
bioactive IBs is a more general feature of the ssTorA tag 
are subjects of further research.
The observation that ssTorA promotes aggregation of 
fused proteins was very surprising and counterintuitive. 
Signal sequences normally mediate membrane target-
ing of fused proteins that are kept in a soluble and trans-
location competent conformation by interaction with 
cytosolic chaperones such as SecB and DnaK [45]. TorA 
belongs to a family of proteins that are equipped with a 
‘twin-arginine’ signal sequence that contains a distinc-
tive SRRxFLK amino acid motif. These signal sequences 
mediate protein transport via the Tat-pathway, which is 
specialized in the translocation of fully folded substrates 
across the cytoplasmic membrane [46]. An intrinsic 
quality control mechanism, sometimes involving spe-
cific signal sequence binding chaperones (e.g. TorD for 
ssTorA) [47], prevents targeting of proteins with a non-
native conformation [48]. IL-3, Pla2, hEGF (all eukaryotic 
proteins) are likely to fold incorrectly in the E. coli 
cytoplasm and may be incompatible with Tat-export. 
However, while TrxA and MBP are compatible with Tat-
mediated translocation when fused to ssTorA [49, 50], 
we observed that overexpression of ssTorA/TrxA and 
ssTorA/MBP resulted in IB formation. Surprisingly, the 
overexpression conditions used even caused efficient IB 
formation of full-length TorA (mature TorA coupled to 
its cognate ssTorA) (Additional file 8: Figure S8). Appar-
ently, ssTorA-dependent IB formation is not per se driven 
by an incompatibility of cargo proteins with the Tat-
dependent export pathway.
Fusion to ssTorA has been successfully used to trans-
port heterologous proteins such as GFP across the E. coli 
inner membrane into the periplasm [51]. Instead, in the 
present work we demonstrate efficient IB-formation of 
cargos upon attachment of ssTorA, including GFP (see 
Additional file  7: Figure S7). The discrepancy between 
these results may find its origin in the different expres-
sion regimes used. Export of ssTorA/GFP to the periplas-
mic space seems to rely on conditions ensuring modest 
expression levels such as the use of reduced growth tem-
peratures or sub-saturating concentrations of inducing 
agent [51, 52]. In contrast, we overexpressed proteins to 
high cellular abundance (e.g. see Figs. 2, 4) from a high-
copy number vector, under control of the reportedly 
very strong and robust tetA promoter [53, 54]. Further-
more, we made use of saturating amounts of anhydro-
tetracycline to induce expression. Conceivably, these 
high-expression conditions are key to mediate efficient 
Fig. 7 Expression and inclusion body formation of the toxin SymE in the absence and presence of fused ssTorA. a Growth curves for E. coli TOP10F’ 
cells expressing SymE or ssTorA/SymE as indicated. Cells were grown to an OD660 of 0.3 when expression of SymE or ssTorA/SymE was induced by 
addition of anhydrotetracycline. Error bars indicate standard deviation; n = 3. b Inclusion body formation of SymE and ssTorA/SymE in the cultures 
described under a analyzed and displayed as described in the legend to Fig. 4
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insoluble expression of heterologous proteins using 
ssTorA. It should be mentioned that successful IB forma-
tion is not restricted to tetA driven expression since high-
level expression of full-length TorA from the araBAD 
promoter (Additional file  8: Figure S8) and lacUV5-
controlled expression of a fusion comprising ssTorA and 
the 143  kDa autotransporter Hemoglobin protease [55] 
(Additional file  9: Figure S9) also resulted in efficient 
IB-formation.
What is the molecular basis of ssTorA-mediated IB for-
mation? IBs form when proteins exposing hydrophobic 
segments specifically cluster in a nucleation-dependent 
mechanism [56, 57]. Nucleation of aggregation may start 
when excess ssTorA-fusions, carrying improperly folded 
and translocation-incompatible cargos, arrive at the inner 
membrane and stall in an unproductive attempt to get 
translocated via the Tat-machinery. In an alternative sce-
nario, overexpression of ssTorA-fusion proteins leads to 
an imbalance between ssTorA and its cognate chaperone 
TorD, which is poorly expressed in regular growth media 
lacking elevated levels of the compound TMAO [58]. 
This may lead to interaction between the relatively hydro-
phobic TorA signal sequences [59, 60] and support the 
nucleation required for IB formation. The additive effect 
of the attachment of multiple signal sequences is in line 
with this scenario. Alternatively, overexpression of ssTorA 
may cause titration of cytosolic chaperones like DnaK and 
GroEL with reported (Tat-)signal sequence- binding prop-
erties [61, 62]. Given the generic role of these chaperones 
in preventing protein misfolding [63], their sequestration 
by ssTorA could result in aggregation of fused cargo pro-
teins. In a fourth scenario, fusion of ssTorA forces a con-
formation upon the fused cargo protein that is prone to 
aggregation. Current research in our laboratory is focused 
on resolving which of these scenarios is correct.
Conclusions
We have identified the signal sequence of E. coli TorA 
as a small and robust, versatile fusion tag that mediates 
efficient IB formation of proteins upon overexpression in 
E. coli. As such, the ssTorA IB-tag seems a valuable tool 
for the time- and cost-efficient production of proteins in 
general and the production of difficult-to-express pro-
teins in particular.
Methods
Strains, media and growth conditions
Escherichia coli K-12 strains TOP10F’ (Invitrogen, UK), 
MC4100 [64] and HDB37 (MC4100 araΔ) [65], as well 
as E. coli B strain BL21(DE3) (Novagen, Germany) were 
used for protein expression, as indicated. Cells were 
grown in LB medium in a shake incubator in the pres-
ence of ampicillin (100 μg/ml). Cultures were grown at 
37 °C in flasks in a shake incubator (200 rpm) using a 5:1 
flask:culture volume ratio.
Reagents and sera
The Rapid Dephos & Ligation Kit was obtained from 
Roche Applied Science. Phusion High Fidelity DNA 
polymerase was purchased from New England Biolabs 
(NEB). DNA restriction enzymes were from Roche or 
NEB. Lumi-Light Western Blotting Substrate was sup-
plied by Roche. Skim milk was purchased from Thermo 
Fisher Scientific. Lysozyme and all other chemicals were 
purchased from Sigma-Aldrich. The rabbit polyclonal 
antisera against recombinant hEGF (ab9697) and TrxA 
(T0803) were from Abcam and Sigma Aldrich, respec-
tively. Rabbit polyclonal antisera against trigger factor 
and OmpA were from our own lab collections, whereas 
the polyclonal antiserum against DsbA was from the sera 
collection of the laboratory of J. Beckwith (Harvard Med-
ical School, Boston, MA, USA).
Plasmid construction
The plasmids and primers used in this study can be found 
in Additional file  10: Table S1 and Additional file  11: 
Table S2, respectively. Details on the construction of 
plasmids can be found in Additional file 12 (Supplement 
methods).
IB sedimentation assay
To separate IBs from the soluble cell content, a culture 
volume containing the number of cells that gives an opti-
cal density (660 nm) of 1.5 in a 1 ml suspension was sub-
jected to centrifugation. The pelleted intact cells were 
resuspended in 750 μl ice-cold lysis buffer (5 mM Tris–
HCl, pH 7.6, 1 mM EDTA, 100 mM NaCl). Lysozyme was 
added to a final concentration of 17 ng/ml and cells were 
incubated on ice for 15 min. Subsequently, the cells were 
disrupted by freeze-thawing and tip sonication (Bran-
son Sonifier 250). The resulting lysate was centrifuged 
(4500×g, at 4  °C for 10 min) to sediment IBs and other 
dense, insoluble material. The resulting pellet was sub-
jected to SDS-PAGE analysis directly, whereas the super-
natant was trichloroacetic acid precipitated first. Intact 
cells directly subjected to SDS-PAGE analysis served as a 
control for total cell content.
General protein expression and analysis
Plasmid-based protein expression was induced using 
anhydrotetracycline (0.2  µg/ml) (IBA GmbH) when 
cell cultures reached an OD660 of approximately 0.3. 
For analysis, cells and cell-fractions were resuspended 
in SDS-sample buffer (125  mM Tris–HCl pH 6.8, 4% 
SDS, 20% glycerol, 0.02% bromophenolblue, 83  mM 
DTT) and incubated at 96  °C for 10 min. Proteins were 
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analyzed by SDS-PAGE and Coomassie Brilliant Blue G 
(Jansen Chimica) staining or Western blotting. Commer-
cial Bis–Tris NuPAGE (Invitrogen) or TGX gels (Biorad) 
were used where appropriate. Imaging and densitometric 
quantification of Coomassie-stained gels was carried out 
using a GS-800 densitometer (Biorad) in combination 
with Quantity-One software (Biorad). For Western blot-
ting, proteins were transferred to nitrocellulose mem-
branes (GE Healthcare). Membranes were blocked using 
buffer TBS-T (TBS, 0.1% Tween-80) containing with 5% 
(w/v) skim milk. Membranes were incubated with pri-
mary antibodies in TBS-T containing 2.5% (w/v) skim 
milk for 1  h at room temperature. After washing with 
TBS-T, the membranes were incubated with peroxidase-
conjugated anti-rabbit IgGs (1:10,000) (Rockland Immu-
nochemicals) in TBS-T containing 2.5% (w/v) skim milk 
for 1 h at room temperature. After washing with TBS-T, 
immunoreactive bands were detected by chemilumi-
nescence using Lumi-Light Western blotting substrate 
(Roche). Signals were captured using a Fluor-S MultiIm-
aging system (Biorad).
Phase‑contrast microscopy
Unless stated otherwise, the following procedure was 
used to perform phase-contrast microscopy: Cells were 
first fixed by incubation in PBS containing 2.8% formal-
dehyde and 0.04% glutaraldehyde at room temperature 
for 15 min. The cells were kept cold during all subsequent 
procedures. To remove residual formaldehyde and glu-
taraldehyde, the cells were collected by low-speed cen-
trifugation, transferred to a new tube and resuspended 
in fresh PBS. After three additional washings in PBS, 
the cells were resuspended in PBS before immobiliza-
tion on 1% agarose in water slab-coated object glasses 
as described [66]. Samples were photographed with a 
CoolSnap fx (Photometrics) CCD camera mounted on 
an Olympus BX-60 fluorescence microscope through a 
UPLANFl 100 × /1.3 oil objective. Images were acquired 
with Micro-Manager (http://www.micro-manager.org/) 
with direct output of the desired hyperstack structure for 
ImageJ by Wayne Rasband (http://imagej.nih.gov/ij/).
Isolation and electron microscopy of IBs
To isolate IBs for EM analysis, cells were collected by 
centrifugation 2 h and 30 min after induction of protein 
expression. The cells were resuspended in Lysis buffer 
(10 mM Tris–HCl pH8, 1 mM EDTA, 5 μg/ml lysozyme), 
incubated at 37 °C for 1 h and 15 min, and lysed using a 
tip sonicator (Branson Sonifier 250). The resulting lysate 
was subjected to centrifugation (15,000×g, 15  min) to 
sediment the IBs. To remove contaminants, the pel-
leted IB material was subjected to a number of consecu-
tive washing steps: The IBs were resuspended in 10 mM 
Tris–HCl pH8, 1  mM EDTA using tip sonication, after 
which the suspension was mixed with an equal volume 
of Triton Wash Buffer (10  mM Tris–HCl pH8, 1  mM 
EDTA, 2% Triton X-100) and incubated at room tem-
perature for 1  h. IBs were collected by centrifugation 
(15,000×g, 15  min) and resuspended in 10  mM Tris–
HCl pH8 using tip sonication. After addition of an equal 
volume of Urea Wash buffer (10 mM Tris–HCl pH8, 2 M 
Urea) the suspension was incubated at room tempera-
ture for 1  h. IBs were again collected by centrifugation 
(15,000×g, 15  min), resuspended in 10  mM Tris–HCl 
pH8 using sonication, and an equal volume of High 
Salt Wash buffer (10  mM Tris–HCl pH8, 2  M NaCl) 
was added. IBs were then sedimented by centrifugation 
(15,000×g, 25  min), resuspended in 10  mM Tris–HCl 
pH8 by sonication, again sedimented by centrifugation 
(15,000×g, 25 min), and resuspended in PBS containing 
15% glycerol.
For electron microscopy analysis, the IBs were spotted 
on carbon coated Formvar grids (FCF300-Ni, Aurion) 
for 5 min, and washed 5 times on water droplets. Nega-
tive staining was performed using 3.5% uranyl acetate for 
5  min, after which excessive staining was removed and 
the grids were air dried. Samples were analysed at 120 kV 
on a Tecnai 12 (FEI) microscope.
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